Connection

Susan Sonne to Female

This is a "connection" page, showing publications Susan Sonne has written about Female.
Connection Strength

0.253
  1. Development and pilot testing of a video-assisted informed consent process. Contemp Clin Trials. 2013 Sep; 36(1):25-31.
    View in: PubMed
    Score: 0.024
  2. The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. Am J Addict. 2010 Mar-Apr; 19(2):111-8.
    View in: PubMed
    Score: 0.019
  3. Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder. Am J Addict. 2003 Oct-Dec; 12(5):412-23.
    View in: PubMed
    Score: 0.012
  4. Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021 01 14; 384(2):140-153.
    View in: PubMed
    Score: 0.010
  5. Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence. J Clin Psychopharmacol. 2000 Feb; 20(1):114-5.
    View in: PubMed
    Score: 0.009
  6. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
    View in: PubMed
    Score: 0.009
  7. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111.
    View in: PubMed
    Score: 0.009
  8. The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Res Health. 1999; 23(4):263-71.
    View in: PubMed
    Score: 0.009
  9. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66.
    View in: PubMed
    Score: 0.008
  10. Diagnosis of personality disorders in cocaine-dependent individuals. Am J Addict. 1998; 7(1):1-6.
    View in: PubMed
    Score: 0.008
  11. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
    View in: PubMed
    Score: 0.008
  12. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
    View in: PubMed
    Score: 0.008
  13. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20.
    View in: PubMed
    Score: 0.008
  14. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144.
    View in: PubMed
    Score: 0.008
  15. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22.
    View in: PubMed
    Score: 0.007
  16. Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence. J Subst Abuse Treat. 2015 Oct; 57:70-4.
    View in: PubMed
    Score: 0.007
  17. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
    View in: PubMed
    Score: 0.006
  18. Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994 Jun; 182(6):349-52.
    View in: PubMed
    Score: 0.006
  19. A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers. J Clin Psychiatry. 2014 Apr; 75(4):336-43.
    View in: PubMed
    Score: 0.006
  20. A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug Alcohol Depend. 2013 Dec 15; 133(3):845-51.
    View in: PubMed
    Score: 0.006
  21. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):112-8.
    View in: PubMed
    Score: 0.006
  22. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46.
    View in: PubMed
    Score: 0.005
  23. Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):472-8.
    View in: PubMed
    Score: 0.005
  24. Improving the transition from residential to outpatient addiction treatment: gender differences in response to supportive telephone calls. Am J Drug Alcohol Abuse. 2008; 34(1):47-59.
    View in: PubMed
    Score: 0.004
  25. Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat. 2008 Jul; 35(1):68-77.
    View in: PubMed
    Score: 0.004
  26. Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis. 2006 Sep; 194(9):690-6.
    View in: PubMed
    Score: 0.004
  27. Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet. 2006 May; 78(5):759-769.
    View in: PubMed
    Score: 0.004
  28. Alcohol dependence and posttraumatic stress disorder: differences in clinical presentation and response to cognitive-behavioral therapy by order of onset. J Subst Abuse Treat. 2005 Jul; 29(1):29-37.
    View in: PubMed
    Score: 0.003
  29. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar; 29(3):395-401.
    View in: PubMed
    Score: 0.003
  30. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders? Compr Psychiatry. 2004 Jul-Aug; 45(4):304-10.
    View in: PubMed
    Score: 0.003
  31. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
    View in: PubMed
    Score: 0.003
  32. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
    View in: PubMed
    Score: 0.003
  33. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89.
    View in: PubMed
    Score: 0.003
  34. Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002 Aug; 10(3):276-85.
    View in: PubMed
    Score: 0.003
  35. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety. 2001; 14(4):255-62.
    View in: PubMed
    Score: 0.002
  36. Valproate for alcoholics with bipolar disorder. Am J Psychiatry. 1999 Jul; 156(7):1122.
    View in: PubMed
    Score: 0.002
  37. Posttraumatic stress disorder and cocaine dependence. Order of onset. Am J Addict. 1998; 7(2):128-35.
    View in: PubMed
    Score: 0.002
  38. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry. 1995 Nov; 56(11):502-5.
    View in: PubMed
    Score: 0.002
  39. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995 Mar; 56(3):118-21.
    View in: PubMed
    Score: 0.002
  40. Fluoxetine-associated side effects and suicidality. J Clin Psychopharmacol. 1993 Aug; 13(4):292-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.